An open label randomized multicentre phase IIIb trial comparing parenteral substitution versus best supportive nutritional care in subjects with pancreatic adenocarcinoma receiving 5-FU plus oxaliplatin as 2nd or higher line chemotherapy regarding clinical benefit - PANUSCO.

BMC Cancer
Angela MärtenDirk Jäger

Abstract

Pancreatic cancer is an extremely aggressive malignancy. Subjects are afflicted with a variety of disconcerting symptoms, including profound cachexia. Recent data indicate that the outcome of oncological patients suffering from cancer cachexia could be improved by parenteral nutrition and that parenteral nutrition results in an improvement of quality of life and in prolonged survival. Currently, there is no recommendation of routine use of parenteral nutrition. Furthermore, there is no clear recommendation for 2nd line therapy (or higher) for pancreatic adenocarcinoma but often asked for. PANUSCO is an open label, controlled, prospective, randomized, multicentre phase IIIb trial with two parallel arms. All patients will be treated with 5-fluorouracil, folinic acid and oxaliplatin on an outpatient basis at the study sites. Additionally, all patients will receive best supportive nutritional care (BSNC). In the experimental group BSNC will be expanded with parenteral nutrition (PN). In contrast, patients in the control group obtain solely BSNC. Parenteral nutrition will be applied overnight and at home by experienced medical staff. A total of 120 patients are planned to be enrolled. Primary endpoint is the comparison of the treatm...Continue Reading

References

Jun 12, 2002·Current Treatment Options in Oncology·S J CohenN J Meropol
Jun 12, 2004·Current Opinion in Clinical Nutrition and Metabolic Care·Eduardo J B RamosMichael M Meguid
Dec 8, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Judith D Bauer, Sandra Capra
Sep 27, 2005·Alimentary Pharmacology & Therapeutics·J Ockenga, L Valentini
Apr 25, 2006·Gastroentérologie Clinique Et Biologique·Emmanuel MitryPhilippe Rougier
Apr 28, 2006·JPEN. Journal of Parenteral and Enteral Nutrition·Edward ShangGeorg Kaehler
Nov 10, 2006·Annals of Surgical Oncology·Maurizio BossolaGiovan Battista Doglietto
Jul 4, 2007·Zeitschrift für Gastroenterologie·G AdlerI Kopp
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
May 30, 2009·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·F BozzettiUNKNOWN ESPEN

❮ Previous
Next ❯

Citations

Aug 31, 2010·Current Opinion in Supportive and Palliative Care·Brian Burnette, Aminah Jatoi
May 26, 2012·European Journal of Cancer Care·A HinzS Singer

❮ Previous
Next ❯

Methods Mentioned

BETA
contraception

Clinical Trials Mentioned

ISRCTN60516908

Software Mentioned

PANUSCO
ADDPLAN

Related Concepts

Related Feeds

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Related Papers

Current Treatment Options in Cardiovascular Medicine
François Becker
The Australian and New Zealand Journal of Psychiatry
S Bloch
© 2022 Meta ULC. All rights reserved